FDA cleared does not mean it actually works. Today, the proof.

Run time: 16:28

In today's episode:

1. AZmed's X-ray AI clears fractures, effusions, dislocations
2. FDA clears first digital-pathology breast cancer risk tool
3. Radiologist-plus-AI beats AI alone for clot detection
4. Top journal: FDA cleared isn't FDA proven
5. Ultromics raises 55 million for echo AI
6. FDA now clears an AI device every 31 hours
7. KPMG puts Claude in front of 276,000 staff
8. Anthropic eyes 900-billion valuation, may pass OpenAI
9. Microsoft's 100 agents find 16 Windows flaws
10. xAI ships Grok Build, its first coding agent

TL;DR:

• A fresh wave of FDA clearances (AZmed's AZtrauma for fractures/effusions/dislocations; ArteraAI Breast) lands the same week a top journal warns that "cleared" is not "clinically proven" — the procurement question from yesterday's lung-CXR head-to-head is now everyone's problem.
• KPMG is rolling Claude out to 276,000+ employees as Anthropic courts a $30B raise at a $900B+ valuation that could top OpenAI for the first time.
• New peer-reviewed data shows radiologists plus AI beat AI alone at finding pulmonary embolism — the week's quiet through-line is collaboration and evidence, not replacement.

Sources cited:

• Diagnostic Imaging
• Artera
• AuntMinnie
• Annals of Internal Medicine
• Crescendo AI Healthcare News
• Innolitics 510(k) Year-in-Review
• Anthropic
• Bloomberg
• Microsoft Security Blog
• The Decoder

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.